Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Clifford G. Wlodaver"'
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Introduction: COVID-19 is a novel and devastating disease. Its manifestations vary from asymptomatic to lethal. Moreover, mortality rates differ based on underlying health conditions and ethnicity. We investigated the biochemical rationale behind the
Externí odkaz:
https://doaj.org/article/687b7f4804974b6d93f6c7d50fcc9782
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Frontiers in Medicine
Frontiers in Medicine
Introduction: COVID-19 is a novel and devastating disease. Its manifestations vary from asymptomatic to lethal. Moreover, mortality rates differ based on underlying health conditions and ethnicity. We investigated the biochemical rationale behind the
Autor:
Clifford G, Wlodaver, Chris, May
Publikováno v:
The Journal of the Oklahoma State Medical Association. 110(1)
The multiple drug resistant organism (MDRO) and Clostridium difficile infection (CDI) epidemics are progressing relentlessly. Antibiotic stewardship (ABS) has evolved to confront these scourges. The Joint Commission has formulated a standard for its
Publikováno v:
Infectious Diseases in Clinical Practice. 20:12-17
Autor:
Clifford G, Wlodaver
Publikováno v:
The Journal of the Oklahoma State Medical Association. 107(1)
Tracking temperatures graphically, recognizing their normal quotidian variations, and acknowledging that fever may be a beneficial physiological response to infection, have been lost in modern hospital care. Further, injudicious use of antibiotics fo
Autor:
Clifford G, Wlodaver
Publikováno v:
The Journal of the Oklahoma State Medical Association. 105(4-5)
Publikováno v:
Infectious Diseases in Clinical Practice. 22:318-319
Autor:
Rob Roy MacGregor, Bienvenido G. Yangco, Amy L. Graziani, Lee E. Tobey, Clifford G. Wlodaver, Daniel J. Sexton
Publikováno v:
Current Opinion in Infectious Diseases. 4:S20-S23
One hundred and two patients were enrolled in an open-label evaluation of intramuscular imipenem/cilastatin using doses of either 500 or 750 mg every 12 h in the treatment of mild to moderately severe skin and soft tissue infections. Seventy-four of
Publikováno v:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 29(3)
Background: Complications following vaccination with vaccinia virus have been well described but are not commonly observed. The use of vaccinia as a tool in molecular biology, in the development of therapeutics, and the anticipated increase of vaccin
Autor:
Mark A. Gill, F. C. Chenella, Gary Milkovich, Gary B. Calandra, Rob Roy MacGregor, Amy L. Graziani, F. Christensen, Albert E. Yellin, Clifford G. Wlodaver, J. D. Rogers, Maria D. Appleman, F.M. Kalian, Javier Garau, Peter N.R. Heseltine, James A. McGregor, J.I. French, Lawrence J. Eron, Lee E. Tobey, Christopher J. Piazza, Bienvenido G. Yangco, Thomas V. Berne, Daniel J. Sexton
Publikováno v:
Chemotherapy. 37:I-III